The treatment is known as 3D interstitial high-dose-rate brachytherapy, a technique that delivers radiation directly inside the tumour rather than from outside the body.

Australian researchers from Southern Cross University (SCU) and the Melbourne Integrative Oncology Group (MIOG) will launch a clinical study investigating whether hyperbaric oxygen therapy (HBOT) can ...

New research from a University of Cincinnati Cancer Center study found external beam radiation therapy (EBRT) is safe to ...

Stage 1 mixed cellularity Hodgkin lymphoma is often highly treatable, and many patients achieve long-term remission after frontline therapy. Advances in chemotherapy, radiation techniques and targeted ...

A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with ...

Stanford Medicine pediatric hematologist Agnieszka Czechowicz, MD, Ph.D., has devoted her research career to improving ...

A prospective, multicenter phase 2 trial evaluated the safety of neoadjuvant radiation plus immunotherapy before radical cystectomy for bladder cancer.

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...

Exercise may reduce cancer-related cognitive impairment among people starting chemotherapy, according to results of a ...

Triple-negative breast cancer is one of the most aggressive and difficult forms of breast cancer to treat. Unlike many other types of breast cancer, it does not have the common hormone receptors that ...

Particle therapy is revolutionizing radiation oncology by enabling highly precise, individualized cancer treatments. As technology evolves, the integration ...

Wellstar West Georgia installs a second Varian TrueBeam system in LaGrange, expanding precise radiation therapy and cutting ...